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The main objectives of this work were to investigate the effect of atmospheric cold plasma
(ACP) against a range of microbial biofilms commonly implicated in foodborne and health-
care associated human infections and against P. aeruginosa quorum sensing (QS)-regu-
lated virulence factors, such as pyocyanin, elastase (Las B) and biofilm formation capacity
post-ACP treatment. The effect of processing factors, namely treatment time and mode of
plasma exposure on antimicrobial activity of ACP were also examined. Antibiofilm activity
was assessed for E. coli, L.monocytogenes and S. aureus in terms of reduction of cultur-
ability and retention of metabolic activity using colony count and XTT assays, respectively.
All samples were treated ‘inpack’ using sealed polypropylene containers with a high voltage
dielectric barrier discharge ACP generated at 80 kV for 0, 60, 120 and 300 s and a post
treatment storage time of 24 h. According to colony counts, ACP treatment for 60 s reduced
populations of E. coli to undetectable levels, whereas 300 s was necessary to significantly
reduce populations of L.monocytogenes and S. aureus biofilms. The results obtained from
XTT assay indicated possible induction of viable but non culturable state of bacteria. With
respect to P. aeruginosaQS-related virulence factors, the production of pyocyanin was sig-
nificantly inhibited after short treatment times, but reduction of elastase was notable only
after 300 s and no reduction in actual biofilm formation was achieved post-ACP treatment.
Importantly, reduction of virulence factors was associated with reduction of the cytotoxic
effects of the bacterial supernatant on CHO-K1 cells, regardless of mode and duration of
treatment. The results of this study point to ACP technology as an effective strategy for inac-
tivation of established biofilms and may play an important role in attenuation of virulence of
pathogenic bacteria. Further investigation is warranted to propose direct evidence for the
inhibition of QS and mechanisms by which this may occur.
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Introduction
Bacterial biofilms represent a significant source of human infections, which may be acquired
through interaction with a wide range of everyday or clinical environments including the con-
sumption of contaminated foods, via hospital environment, medical equipment or devices [1–
2]. In the United States approximately 80% of persistent bacterial infections are associated with
biofilms [3]. Biofilms are defined as complex microbial communities enclosed in hydrated
extracellular polymeric substances (EPS), which comprise polysaccharides, proteins, phospho-
lipids, teichoic and nucleic acids [4]. Due to their heterogeneous nature, bacterial biofilms are
characterized with an enhanced resistance by comparison with their planktonic counterparts
to most environmental stresses including nutrient starvation, oxidative stress, antibiotic expo-
sure and other conditions detrimental to bacterial growth [5–6]. In turn, these stresses can act
as determinants for biofilm formation; indeed the transition from planktonic to biofilm form
can be considered as a stress response mechanism [7–8]. One of the regulatory mechanisms
that bacteria employ to respond to external environmental stresses through the expression of a
large number of genes is quorum sensing (QS), widely defined as a population-controlled bac-
terial communication process [9]. QS regulates numerous important cell functions in both
Gram-positive and Gram-negative bacteria, including metabolism, protein synthesis, expres-
sion of virulence factors, antibiotic resistance, biofilm formation, biofilm maintenance and dis-
persal, and entry to stationary phase, therefore, QS is a highly attractive target in the search for
alternative antimicrobial agents [7, 9–10]. Pseudomonas aeruginosa is an important clinical
pathogen that is extensively studied as a model organism with respect to QS as well as biofilm
formation. P. aeruginosa possesses two individual but interconnected acyl-homoserine lactone
(AHL) based QS signalling systems, las and rhl [10]. The las system regulates the production of
elastases (Las B), protease (Las A), exotoxins and development of biofilms, whereas rhl induces
the production of elastase, proteases, rhamnolipid, pyocyanin and siderophores [11–12]. There
is a third QS signalling molecule in P. aeruginosa termed as Pseudomonas quinolone signal
(PQS), which is also involved in the pyocyanin synthesis. Pyocyanin, which is a redox-active,
blue pigment phenazine, toxic to prokaryotic and eukaryotic cells, is one of the most important
QS-controlled virulence factors produced by P. aeruginosa [13]. By interfering with a wide
spectrum of cellular functions in host cells such as electron transport, cellular respiration,
energy metabolism, gene expression, ciliary function, epidermal cell growth and innate
immune mechanisms, pyocyanin contributes to chronic respiratory infections and sepsis [14–
15]. Another highly toxic virulence factor secreted by P. aeruginosa is the metalloprotease elas-
tase, also known as Las B, which causes tissue damage and invasion, by degradation of elastin,
fibrin and collagen, inactivation of the immune system components, and acts intracellularly to
initiate bacterial biofilm growth [16–17]. The key role of these QS-controlled virulence factors
in the pathogenesis of P. aeruginosa indicates a need to examine and expand antimicrobial
strategies targeting not only structural components of biofilms as well as inactivation of bacte-
rial cells within biofilm complexes but also specifically the inhibition of virulence factors so
that an improved outcome of microbial biofilm inactivation and control of microbial infection
are achieved.
Atmospheric cold plasma (ACP) is a relatively novel approach increasingly studied against
a wide range of microbial pathogens either in planktonic or biofilm form. ACP is often referred
to as the fourth state of matter, which under the constant supply of energy to a gas results in
the generation of photons, electrons, positively and negatively charged ions, atoms, free radi-
cals and excited or non-excited molecules [18]. Although the exact mechanism of ACP bacteri-
cidal action is yet to be elucidated, it is known that atmospheric air ACP is a source of multiple
chemically reactive species, including reactive oxygen (ROS) and reactive nitrogen species
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(RNS), with a high bactericidal potency. Among the ROS, ozone, atomic oxygen, singlet oxy-
gen, superoxide, peroxide, and hydroxyl radicals, independently or in synergy, are expected to
play a role in the bacterial inactivation process [19–20]. Our previous studies demonstrated
that ACP in conjunction with in-package treatment was very effective for reducing high con-
centrations of planktonic bacterial population to undetectable levels within short treatment
times [21]. However, a reduced antimicrobial effect of ACP treatments against bacteria grow-
ing in a biofilm form has been reported [22–24]. Due to the challenge presented by the persis-
tence of biofilms and lack of techniques to overcome these challenges, an effective control of
bacterial biofilms is becoming crucial and should play an important role in the design of disin-
fection strategies. Moreover, because QS may be involved in the formation of biofilms [25], it is
of fundamental research interest to investigate whether ACP technology can specifically inter-
rupt or inhibit bacterial QS systems through interference with virulence factor production.
Therefore, the main objectives of this study were to investigate the potential of ACP for elimi-
nation of challenge monoculture biofilms and to examine inhibition potential against bacterial
virulence factors. Surviving bacterial populations in established biofilms of E. coli, L.monocyto-
genes and S. aureus were estimated by colony count and XTT assays for determination of cell
viability and metabolic activity, respectively. Scanning electron microscopy (SEM) analysis was
conducted to observe any morphological changes of biofilms caused by ACP treatment. Inhibi-
tion of QS was studied only for P. aeruginosa which was selected as the model organism with
respect to QS by measuring concentrations of pyocyanin (rhl), elastase production (las) and
biofilm formation capacity post ACP treatment. Finally, in order to examine if ACP-based
reduction of virulence factors could further influence the toxicity of P. aeruginosa, a cytotoxic-
ity assay using CHO-K1 cell line was conducted. The effects of the processing factors of treat-
ment time and mode of plasma exposure on antimicrobial activity of ACP were examined.
Materials and Methods
Bacterial strains and growth conditions
Bacterial strains utilised in this study were Escherichia coli NCTC 12900, obtained from
National Collection of type cultures of the Health Protection Agency (HPA, UK), Staphylococ-
cus aureusNCTC 1803, Listeria monocytogenes NCTC 11994 and Pseudomonas aeruginosa
ATCC 27853, which were obtained from the microbiology stock culture of the School of Food
Science and Environmental Health of the Dublin Institute of Technology. A single isolated col-
ony of each culture was inoculated in tryptic soy broth without glucose (TSB, ScharlauChemie,
Spain). For biofilm studies, E. coli, L.monocytogenes and S. aureus cultures were incubated for
18 h at 37°C, which were further diluted in TSB to a cell density of 1.0 × 107 CFU/ml and used
as inoculum for biofilm formation. P. aeruginosa was inoculated in TSB and incubated for 24 h
at 37°C and further used in inhibition of QS-controlled virulence factors, i.e. pyocyanin, elas-
tase (Las B) and biofilm formation experiments. Separate experiments to determine pyocyanin
levels were conducted using 24 h grown P. aeruginosa culture cell free supernatant.
Cultivation of CHO-K1 cells
Chinese hamster ovary cells (CHO-K1) were obtained from biological stock culture of the
School of Food Science and Environmental Health of the Dublin Institute of Technology. The
cells were grown in Dulbecco's Modified Eagle's Medium/Ham's F-12 Nutrient Mixture
(DMEM/F12, Sigma-Aldrich Co., Ireland) containing 2 mM L-glutamine and 10% (v/v) foetal
bovine serum (FBS) at 37°C and 5% carbon dioxide (CO2). Confluent cell layers were washed
with phosphate buffered saline (PBS, Sigma-Aldrich Co., Ireland) and enzymatically detached
using trypsin/EDTA.
Cold Plasma Effects on Biofilms and Quorum Sensing
PLOS ONE | DOI:10.1371/journal.pone.0138209 September 21, 2015 3 / 21
Biofilm formation
A 96 well microtiter plate method was used for biofilm formation. Briefly, either E. coli, L.
monocytogenes or S. aureus TSB cell suspension (200 μl) was added into the wells (8 wells for
each replicate) and incubated at 37°C for 48 h, replacing the supernatant with fresh TSB after
the first 24 h of incubation. For scanning electron microscopy (SEM) analysis, E. coli biofilms
were produced using 6 well inserts containing track-etched polyethylene terephthalate (PET)
membranes with 0.4 μm pore size (Becton Dickinson Labware, USA). The inserts were placed
inside the wells of the 6 well culture plate, filled with 2 ml of TSB bacterial suspension
(1.0 × 107 CFUml-1) and incubated for 48 h at 37°C, changing the supernatant after 24 h of
incubation. After 48 h of incubation, the supernatant from either microplate wells or inserts
was removed and substrates were rinsed three times with sterile PBS, leaving only bacterial bio-
films for further investigation. Negative controls were obtained by using uninoculated TSB.
Prior to each experiment, the microtiter plates and 6 well inserts containing biofilms were air
dried for approximately 60 min.
Experimental design
The ACP system utilised was a DBD system previously described in [21], with a maximum
high voltage output of 120 kV at 50 Hz and 22 mm distance between the two aluminium elec-
trodes. The distance was equal to the height of the polypropylene container (310 x 230 x 22
mm), which was used as both a sample holder and as a dielectric barrier. Plasma was generated
in air at 80 kVRMS.
Effects of both direct and indirect ACP treatment were evaluated (Fig 1). Either a microtiter
plate or PET membrane insert containing bacterial biofilms or a petri dish containing P. aeru-
ginosa cells TSB suspension or P. aeruginosa cell-free supernatant (10 ml) were placed in the
centre of the plastic container directly between the electrodes within the plasma discharge for
direct ACP treatment and were thus exposed to all generated reactive species, such as charged
particles, positive and negative ions, electrons, free radicals, excited and non-excited molecules
and atoms, heat and UV photons [26]. The distance between the sample and top electrode for
direct treatment was approximately 10 mm. For indirect ACP treatment, a separate container
was used and samples were uniformly placed at some distance from the plasma discharge [21]
so as to achieve treatment outside the plasma discharge where the antimicrobial effects are
mainly attributed to long-lived radicals and recombined products [26]. The distance between
the samples and centre of the electrodes for indirect treatment varied from 120 mm to 160 mm
due to samples distribution in the microtiter plate or in petri dish. After sample loading, each
polypropylene container was sealed with a high barrier polypropylene bag (Cryovac, B2630,
USA) and placed between the aluminium electrodes of the transformer. The samples were
treated with either direct or indirect ACP for 60, 120 and 300 s. The temperature of the surface
of TSB cell suspension and the 96 well plate measured immediately after 300 s of direct/indirect
treatment using IR thermometer (Maplin Electronics, S63 5DL, UK) was 21/17°C and 24/18°C,
respectively, whereas the temperature measured at the centre of the polypropylene container
did not exceed 28°C. All treated samples were subjected to a post treatment storage time of 24
h at room temperature. Control samples were left untreated (0 h control) to estimate initial
bacterial concentration, elastolytic activity and pyocyanin levels. To assess possible effects of 24
h of post treatment storage on bacterial viability and enzymatic activity a separate set of
untreated samples were stored for 24 h under conditions identical to post treatment storage.
All biofilm-based experiments were conducted by using three independently grown cultures
and repeated at least twice.
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Biofilm assays
Colony count assay. To determine the effect of ACP treatment on the viability of cells
within biofilms formed in 96 well microtiter plates, 200 μl of sterile PBS were added into the
wells. The plates were then sonicated using a water table sonicator (Bransonic 5510E-MT,
USA, Mexico) for 5 min in order to disrupt biofilms. PBS cell suspensions of corresponding
culture were pooled together from the wells into sterile eppendorf tubes and serially diluted in
maximum recovery diluent (MRD, ScharlauChemie, Spain). Aliquots of appropriate dilutions
(100 μl) were surface plated on TSA and incubated at 37°C for 24–48 h. Results were presented
as surviving bacterial population in Log10 CFUml
−1 units.
XTT assay. To examine the effect of ACP treatment on metabolic activity of bacterial cells
in biofilms a 2,3-bis (2-methoxy-4-nitro-5-sulfophenyl) [phenyl-amino)car-bonyl]-2H-
Fig 1. Experimental set up. Either a microtiter plate containing bacterial biofilms or a petri dish containing P. aeruginosa cells TSB suspension or cell-free
supernatant were placed inside the plastic container between the electrodes for direct ACP treatment. For indirect ACP treatment, a separate container was
used and samples were placed outside the plasma discharge.
doi:10.1371/journal.pone.0138209.g001
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tetrazolium hydroxide assay (XTT, 1 mg/ml, Sigma-Aldrich Co., Ireland) was utilised following
the procedure previously described by [27]. Briefly, wells containing biofilms and negative con-
trols (TSB without inocula) were filled with sterile PBS (100 μl) and fresh solution of XTT-
menadione (100 μl) was added to all wells. Following incubation for 5 h at 37°C in the dark,
supernatant (100 μl) from each well was transferred into the wells of a new 96 well microtiter
plate and the absorbance was measured at 486 nm on a microplate reader (Synergy HT, Biotek
Instruments Inc.). The percentage of surviving bacterial population was calculated as ((AACP-
AC)/A0) X100%, where AACP, AC and A0 are the absorbance of ACP treated, negative control
and untreated control biofilms, respectively.
Scanning electron microscopy (SEM). E. coli biofilms; untreated 0 h controls and samples
directly treated with ACP for 300 s were selected for SEM analysis. Following fixation for 2 h in
ice-cold 2.5% glutaraldehyde in 0.05 M sodium cacodylate buffer (pH 7.4) (SCB), cells were
washed with the same buffer and fixed in 1% osmium tetroxide for 2 h at 4°C. After 2 h of fixa-
tion, cells were washed with SCB followed by three washes with distilled water. Samples were
treated with increasing concentrations of ethanol (30%, 50%, 70%, 80%, 95%, and 99.5%) and
dehydrated using 33%, 50%, 66%, and 100% (v/v) hexamethyldisilazane (Sigma Aldrich, Ire-
land). Samples were sputter-coated with gold particles using an Emitech K575X Sputter Coat-
ing Unit resulting in a coating of 10 nm after 30 s. The samples were examined visually using a
FEI Quanta 3D FEG Dual Beam SEM (FEI Ltd, Hillsboro, USA) at 5 kV.
P. aeruginosaQS-controlled virulence factors assays
Pyocyanin assay. Pyocyanin (rhl-controlled QS system) present in P. aeruginosa TSB sus-
pension or supernatant was extracted following the procedure described by [28]. Briefly, either
untreated (0 h and 24 h controls) or ACP treated and stored for 24 h post treatment bacterial
cell suspensions or culture supernatants, were centrifuged for 10 min at 10,000 rpm. Each
supernatant (5 ml) was transferred into a 25 ml tube containing 3 ml of chloroform and the
resulting chloroform layer (3 ml) was mixed with 1.5 ml of 0.2 M hydrochloric acid. The solu-
tion containing extracted pyocyanin (top layer) was transferred into the wells of a 96 well plate
and the absorbance was measured using a microtiter plate reader at 520 nm. An average absor-
bance value obtained from 10 wells was corrected by subtracting the mean of the absorbance of
a blank (uninoculated) TSB. Experiments were repeated at least three times.
Elastin-Congo red assay. The effect of ACP treatment on P. aeruginosa elastolytic activity
(Las B), controlled by the las QS system, was determined using elastin-Congo red conjugate
(Sigma Aldrich, Ireland), as the most specified substrate for elastase, following the procedure
described by [29]. Either untreated 0 h and 24 h controls or ACP treated bacterial suspensions
were centrifuged for 10 min at 10,000 rpm. Elastin-Congo red (2.5 mg) was suspended in
500 μl of 0.2 M Tris buffer (pH 8.8) in an eppendorf, vortexed, and mixed with 500 μl of P. aer-
uginosa supernatant. The resulting solution was incubated at 37°C for 24 h. After incubation,
the samples were vortexed and centrifuged at 13,000 rpm for 10 min. The supernatant was dis-
pensed into the wells of the 96 well microtiter plate and the absorbance of released Congo red
was measured at 495 nm. An average absorbance, corrected by the mean absorbance obtained
from the corresponding mixture incubated in the absence of elastin-Congo red, represents P.
aeruginosa enzymatic elastase activity. Experiments were repeated at least five times.
Planktonic cell population density. The possible changes in concentrations of P. aerugi-
nosa planktonic cell populations caused by ACP treatment were monitored conducting colony
count assay of bacterial samples treated with ACP either directly or indirectly for 60, 120, and
300 s and untreated 0 h and 24 h controls. Experiments were repeated at least six times and
results were presented as surviving bacterial population in Log10 CFUml
−1 units.
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Biofilm formation assay. The effect of ACP treatment on P. aeruginosa biofilm formation
was examined using colony count assay. Samples treated with ACP and stored for 24 h or
untreated 0 h and 24 h controls of P. aeruginosa TSB suspensions were dispensed into the wells
of 96 well microtiter plates (200 μl). The plates were incubated for 24 h at 37°C. After incuba-
tion, the reduction in culturability of P. aeruginosa biofilms was assessed by colony count assay
as described in section 2.4.1. Experiments were duplicated and repeated at least twice. Results
were presented as surviving bacterial population in Log10 CFUml
−1 units.
Cytotoxicity assay
To examine if ACP-based reduction of virulence factors could further influence cytotoxicity of
P. aeruginosa, a cytotoxicity assay using the CHO-K1 cell line was conducted. Detached cells,
seeded in 96 well microtiter plates at final concentration of 2.5 x 104 cells/ml (100 μl per well),
were supplemented with 10 μl of filter-sterilised supernatant of either ACP treated or untreated
(0 h and 24 h controls) P. aeruginosa cell suspension (filter pore size 0.2 μm). Uninoculated
and ACP treated TSB medium were considered as negative controls. Cell growth/adhesion was
assessed after incubation at 37°C and 5% CO2 in air for 3 days using crystal violet assay (CV).
Briefly, after incubation, supernatants were removed and adherent cell layers were fixed with
40 μl 70% methanol for 1 min. After fixation, cells were stained with 50 μl of 0.2% CV solution
for 10 min and then extensively washed with water. Adherent CV was dissolved in 10% acetic
acid (100 μl per well) and the absorbance was measured at 600 nm on a microplate reader.
Results are represented as a percentage of adherent cells determined by the absorbance of the
CV, where cell culture supplemented with uninoculated and untreated TSB medium was set as
a 100%. Experiments were performed in triplicate and replicated at least three times.
Statistical analysis
Statistical analysis was performed using SPSS 19.0 (SPSS Inc., Chicago, USA). The surviving
populations of challenge bacteria and reduction of pyocyanin and elastolytic activity in P. aeru-
ginosa following ACP treatment were subjected to analysis of variance (ANOVA). Means were
compared according to the method of Fisher’s Least Significant Difference-LSD at the 0.05
level. Absorbance values of CHO-K1 cells obtained from the exposure to untreated TSB, P. aer-
uginosa 0 h and 24 h controls and ACP treated for 60, 120 and 300 s of corresponding groups,
i.e. the type of media (P. aeruginosa and TSB) and type of treatment (direct and indirect) were
compared according to the method of LSD at the 0.05 level.
Results
Effect of ACP on bacterial biofilms
Colony count assay. Surviving populations of E. coli, L.monocytogenes, S. aureus 48 h bio-
films as a function of treatment time and exposure type are presented in Fig 2. The average ini-
tial population of E. coli recovered from untreated control biofilms was 5.4 ±0.87 log10 CFU/ml
(Fig 2A). On average, population densities were reduced below the detection limit of 1.0 log10
utilising either direct or indirect type of exposure and for all treatment times applied.
L.monocytogenes biofilm populations were reduced (p! 0.05) from the mean value of 6.3
±0.25 log10 CFU/ml before treatment (0 h control) to an average of 2.8 log10 CFU/ml after 60 s
of direct/indirect treatment (Fig 2B). Extending treatment time to 120 s using direct exposure
did not enhance antimicrobial effect, however, 120 s of indirect treatment reduced cell numbers
to an average of 1.9 ±0.42 log10 CFU/ml (p! 0.05). Extending treatment to 300 s using direct
exposure did yield significant reductions of L.monocytogenes cells in biofilms to an average of
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Fig 2. Surviving populations of bacterial biofilms after ACP treatment assessed by colony count
assay. (A) E. coli, (B) L.monocytogenes and (C) S. aureus: (Δ) untreated 24 h control, (^) after direct and (□)
indirect ACP treatment. Vertical bars represent standard deviation. Limit of detection 1.0 log10 CFU/ml. For
each microorganism, all experiments were conducted in triplicate using independently grown cultures and
replicated at least twice.
doi:10.1371/journal.pone.0138209.g002
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1.1 ±0.94 log10 CFU/ml, and L.monocytogenes was undetectable when exposed to indirect
treatment for 300 s.
The inactivation effect of ACP treatment against S. aureus biofilms is shown in Fig 2C,
where similar reductions were observed with either direct or indirect ACP exposure. However,
there was no significant difference between the population density after 60 s of treatment and
the 24 h controls. Increasing treatment time did reduce populations further, where the popula-
tion densities surviving 120 s and 300 s of treatment significantly differed from the 24 h storage
control biofilm (p! 0.05).
XTT assay. Effects on viability and metabolic activity of E. coli, L.monocytogenes, S. aureus
48 h biofilms after direct or indirect ACP treatment and 24 h of post treatment storage time are
presented in Fig 3. For the three test microorganisms, there was no significant difference found
between the effects of direct and indirect ACP exposure. Thus, direct/indirect ACP treatment
for 60 s reduced E. coli cells metabolic activity by an average of 77.7% (Fig 3A). Further increas-
ing treatment time to 300 s yielded a maximum average reduction of 90.0%.
Fig 3B represents the effects of ACP treatment on the metabolic activity of L.monocytogenes
cells in biofilms. XTT absorbance values indicate a correlation between ACP inactivation effi-
cacy with increased treatment time. Direct treatment for 60, 120 and 300 s significantly reduced
metabolic activity of L.monocytogenes cells to an average of 55.5 ±15.7%, 30.6 ± 22.5% and 8.7
±16.2%, respectively, compared to the untreated 0 h control (p! 0.05). In the case of indirect
treatment, a similar trend was observed, where the percentage of metabolically active cells sig-
nificantly decreased to an average of 49.5 ±22.9%, 20.8 ±18.5% and 3.8 ±7.9% after 60, 120 and
300 s of indirect treatment, respectively, with reference to the 0 h control.
A rapid decline in cell metabolic activity following both direct and indirect ACP treatment
was observed for S. aureus biofilms (Fig 3C). The average percentage of cells surviving 60 s of
treatment was 23.5%, which decreased to almost nil as treatment time increased. There was no
statistical difference found between percentage absorbance values obtained from 0 h and 24 h
controls in the case of the three microorganisms examined.
Scanning electron microscopy (SEM). SEM analysis was utilised in order to visualise the
effect of ACP treatment on bacteria in the form of a complex biofilm structure. Fig 4 represents
SEM images obtained for 48 h E. coli biofilms, showing either untreated 0 h control or biofilm
treated with ACP for 300 s using direct exposure. Images of the E. coli control sample con-
firmed the presence of healthy cells and biofilm matrix formation (Fig 4A), whereas after ACP
treatment, a large proportion of bacterial cells was disintegrated and cell debris fragments were
found on the surface of PET membrane (black arrows) (Fig 4B). However, in several areas of
the ACP treated membrane, the bacterial cells remained intact (white arrow).
Effect of ACP on P. aeruginosaQS-controlled virulence factors
The effects of ACP on P. aeruginosaQS-controlled virulence factors were investigated utilising
bacterial cell suspension (Fig 5). In a parallel study P. aeruginosa cell free supernatant was used
to examine any possible effect of cells present during the treatment in the TSB media on the
levels of pyocyanin. In general, both direct and indirect ACP treatment resulted in similar
reduction of both pyocyanin and elastase levels. The levels of pyocyanin retained after ACP
treatment and 24 h of post treatment storage are shown on Fig 5A. Short treatment for 60 s by
either direct or indirect ACP significantly reduced concentrations of pyocyanin by 70.7 ±9.68%
and 88.5 ±11.34%, respectively (p! 0.05), compared to 0 h control. The levels of pyocyanin in
the cell free culture supernatant were reduced by an average of 60.8 ±14.34% and 68.0 ±12.77%
after 60 s of direct and indirect treatment (Fig 5B), respectively, whereas 300 s of treatment
almost completely inactivated pyocyanin in both the cell suspension and the cell free
Cold Plasma Effects on Biofilms and Quorum Sensing
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Fig 3. Percentage surviving populations of bacterial biofilms after ACP treatment assessed by XTT
assay. (A) E. coli, (B) L.monocytogenes and (C) S. aureus: (Δ) untreated 24 h control, (^) after direct and (□)
indirect ACP treatment. Vertical bars represent standard deviation. For each microorganism, all experiments
were conducted in triplicate using independently grown cultures and replicated at least twice.
doi:10.1371/journal.pone.0138209.g003
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supernatant (Fig 5A and 5B). In contrast, slower inhibition rates of elastolytic activity were
recorded (Fig 5C). According to the absorbance values measured at 495 nm, only direct treat-
ment for 300 s yielded a significant reduction in the elastolytic activity of elastase by compari-
son with the 0 h control (p! 0.05). However, elastase levels after 300 s of either direct or
indirect treatments were lower than the corresponding 24 h untreated controls (p! 0.05). In
order to ensure that the reduction of P. aeruginosa virulence factors was not due to the bacteri-
cidal action of ACP, the numbers of planktonic cells in TSB were estimated using colony count
Fig 4. Scanning electron microscopy images of E. coli 48 h biofilms. (A) untreated 0 h control
(magnification 25 000X) and (B) after 300 s of direct ACP treatment (magnification 10 000X). Black arrows
indicate cell debris; white arrows indicate intact cells.
doi:10.1371/journal.pone.0138209.g004
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Fig 5. ACP inhibition effects on P. aeruginosa virulence factors. (A) pyocyanin in the presence of cells, (B) pyocyanin in the cell free medium
(experiments repeated at least three times), (C) elastase Las B (experiments repeated at least five times), (D) planktonic cell concentration (experiments
repeated at least six times) and (E) biofilm formation (experiments were performed in duplicate and replicated at least twice): (Δ) untreated 24 h controls, (^)
after direct and (□) indirect ACP treatment. Vertical bars represent standard deviation.
doi:10.1371/journal.pone.0138209.g005
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assay. From Fig 5D it can be seen that there were no significant changes in bacterial cell popula-
tion density noted after any of the treatment times applied. The ACP treatments also did not
influence the ability of P. aeruginosa to form biofilms, as there was no reduction in cell popula-
tions of the 24 h biofilms initiated from ACP treated cell suspensions (Fig 5E).
Effect of ACP on cytotoxicity of P. aeruginosa
The effects of P. aeruginosa treated with either direct or indirect ACP and stored for 24 h or
untreated and stored for 0 h and 24 h (0 h and 24 h control) on growth/adherence of CHO-K1
cells are presented on Fig 6. Uninoculated TSB subjected to the same treatment were used as
controls and untreated TSB was set as 100% cell growth. Significant reduction by an average of
92.6 ±2.70% in cell growth resulted from the exposure of CHO-K1 to untreated P. aeruginosa
24 h control as compared to the untreated TSB (p! 0.05). Regardless of the type of treatment,
exposure of CHO-K1 to supernatant of P. aeruginosa treated with ACP for 60, 120 and 300 s
increased the growth of cells by an average of 62.4, 72.7 and 77.7%, respectively, by comparison
with P. aeruginosa 24 h untreated controls (p! 0.05).
While there was no significant difference recorded between the growth of CHO-K1 cells as
a result of different treatment times applied against P. aeruginosa cell suspensions, a treatment
time dependent decrease in cell adherence was observed when CHO-K1 were exposed to unin-
oculated and ACP treated TSB medium, where increasing treatment time resulted in reduction
of cell growth by an average of 55.9, 80.8 and 95.4%, respectively. Absorbance values of cultures
exposed to uninoculated TSB treated with ACP for 120 and 300 s were significantly lower than
the values obtained from cells exposed to ACP treated P. aeruginosa supernatants (p! 0.05).
Discussion
Microbial biofilms form on a wide variety of surfaces, including living tissues, indwelling medi-
cal devices, industrial or potable water systems, food and food-contact surfaces, thereby estab-
lishing reservoirs for continuous contamination [4, 30]. In response to an increasing tolerance
of microorganisms to broad-spectrum antibiotics, and resistance of biofilms in particular,
Fig 6. The effect of either untreated (0 h, 24 h controls) or ACP treated P. aeruginosa (P.a) and ACP treated TSBmedium on growth/adherence of
CHO-K1 cells.Different letters indicate a significant difference in % absorbance levels. Vertical bars represent standard deviation. Experiments were
performed in triplicate and replicated at least three times.
doi:10.1371/journal.pone.0138209.g006
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research has focussed on achieving an efficient inactivation and removal of bacterial biofilms.
Among the various methods, ACP technology demonstrated remarkable effectiveness against a
range of microorganisms, including antibiotic-resistant biofilm forming strains [31].
In the current study, a dielectric barrier discharge (DBD) configuration was used to generate
high voltage ACP, and investigated against a range of microbial biofilms commonly implicated
in foodborne and healthcare associated human infections, E. coli, L.monocytogenes and S.
aureus. Either direct or indirect atmospheric air ACP treatment was highly effective against
challenge 48 h biofilms with no significant difference in inactivation efficacy observed between
the modes of ACP exposure. The 24 h of post treatment storage time used in conjunction with
in-package ACP treatment allowed the retention of plasma generated reactive species inside
the pack over time, facilitating bactericidal action of both types of exposure. It is likely that the
reductions obtained after indirect treatment would not be possible to achieve without species
retention, as the action of treatment is mainly based on the reaction of long lived and recom-
bined species rather than on the combined action of charged particles positive and negative
ions, electrons, free radicals, excited and non-excited molecules and atoms associated with
direct treatment. The efficiency of ACP treatment was found to be bacterial type dependant.
Biofilms by their nature are complex biomaterials, the composition of which will vary between
the type and strain of bacteria [32]. According to colony counts, treatment for 60 s reduced
populations of Gram-negative E. coli biofilms to undetectable levels, whereas this treatment
time was less effective for Gram-positive L.monocytogenes and S. aureus biofilms (Fig 2).
Although inactivation of L.monocytogenes biofilms was slower by comparison with the rapid
reduction of E. coli, an extended direct treatment for 300 s reduced L.monocytogenes cells
by> 5.0 log10 CFU/ml and cells recovered after indirect ACP were below detection limits.
Large proportions of S. aureus biofilm populations were inactivated after 60 s of treatment
(~3.0 log10 CFU/ml) with only a small further reduction achieved after treatment time of 300
s, indicating a stronger resistance of this strain. It has been reported that Gram-positive bacte-
ria are more resistant to ACP treatments than Gram-negative bacteria [33–36]. The membrane
structure of the Gram-positive bacteria may present a barrier to the diffusion of ACP reactive
species through the bacterial cell wall, thus impacting ACP antimicrobial efficacy. The different
modes of ACP action against Gram-positive bacteria and Gram-negative have been also
reported. For example, cell membranes of L. innocua remained intact during ACP treatment
and ACP generated species reacted with cellular components [37], whereas both the cell mem-
brane and cellular components of E. coli were affected. In contrast, there was no difference in
inactivation efficacy of ACP between Gram-negative and Gram-positive bacteria [38], which
suggested that there is no selectivity in the action of ACP generated species based on the bacte-
rial cell wall structure. Moreover, the thickness, composition and quantity of the EPS may vary
depending on the type of microorganisms [32], which could consequently impact ACP inacti-
vation efficacy. These questions remain regarding the ACP mechanism of action on bacterial
biofilms. In the current work, in addition to the difference between Gram-positive and Gram-
negative bacteria, different ACP inactivation efficacy was noted for the reductions of biofilms
of the two Gram-positive bacteria, L.monocytogenes and S. aureus, where S. aureus exhibited
higher resistance to treatment than L.monocytogenes. These observations could be related to
the morphology of bacterial cells, where spherical-shaped S. aureus (cocci) may be more resis-
tant to ACP than rod-shaped L.monocytogenes. Similarly, the inactivation efficacy of ultra-
sound can be influenced by the shape of bacterial cells with more resistant spherical cells than
rod-shaped cells [39]. However, the effects of ACP treatment on different bacteria possessing
different cell shape remain unclear and warrant further investigation.
Colony count assay estimates the number of cells that survive treatment and are able to
grow on TSA agar but does not account for cells that might be metabolically active but unable
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to grow. XTT assay was conducted in order to detect the retention of metabolic activity of bacte-
rial cells exposed to ACP treatment (Fig 3). In general a good correlation between results
obtained from XTT and colony counts was found in the case of Gram-positive L.monocytogenes
and S. aureus biofilms. However, corresponding results for Gram-negative E. coli indicated that
although 60 s of treatment was able to reduce bacterial counts to undetectable levels, complete
inactivation of metabolic activity could not be achieved even after 300 s. It is known that under
one or more environmental stresses bacteria may enter Viable-But-Non-Culturable (VBNC) or
so-called dormant state [40], a strategy that bacteria employ to tolerate conditions that are detri-
mental to growth [41]. The results obtained from XTT assay indicated that bacteria were in a
VBNC state due to oxidative stress encountered from chemically reactive species generated by
ACP. These results were supported by SEM analysis conducted to examine changes of E. coli
biofilm morphology after direct ACP treatment for 300 s (Fig 4). The images of treated biofilms
confirmed the bactericidal action of ACP showing significant changes in biofilms, with the
structures altered from healthy cells interconnected by self-produced EPS matrices, to irregu-
larly shaped cell fragments. However, although most of the cells were disintegrated, intact cells
were found after exposure to ACP, suggesting that treatment could not inactivate bacteria
completely as determined by colony count assay. Surviving cells present on ACP treated mem-
brane indicate retention of cell metabolic activity, i.e. presence in their VBNC sate. Recently it
has been demonstrated that, although non-culturable, P. aeruginosa retained its virulence after
relatively short time of ACP exposure resulting in lettuce tissue damage [42]. Microbial patho-
gens in such a state can retain virulence and also pose further challenge as stressed cells may be
of a higher virulence potential than bacteria exposed to favourable growth conditions [43].
P. aeruginosa is known for its diverse pathogenicity and is an ubiquitous, metabolically ver-
satile opportunistic pathogen that causes a wide variety of acute and persistent infections in
humans and is resistant to broad spectrum antibiotic treatments [44]. The resistance of P. aeru-
ginosa to antimicrobials is generally attributed to the reduced cell wall permeability, active mul-
tidrug efflux systems, biofilm formation, plasmid acquisition and mutation due to the stress
encountered from continuous antibiotic use [13, 45]. Inhibition of QS-controlled virulence fac-
tors is a novel approach with a potential to decrease or substitute the use of traditional antibiot-
ics. Recent investigations of the effects of natural and chemically synthesised compounds have
demonstrated that reduction of virulence factor production and prevention of biofilm forma-
tion with aims to control microbial infection is possible through inhibition of one or more
components of the QS system [46–50]. Unfortunately, many known QS inhibition compounds
are themselves cytotoxic at practically useful concentrations, thus limiting their topical and
internal applications in mammalian systems. The potential of ACP treatment to interfere with
virulence of P. aeruginosa was recently demonstrated by Vandervoort and Brelles-Marino [42],
which showed attenuated bacterial virulence after longer treatment duration as tested by the
lettuce assay. Our previous studies demonstrated that in-package ACP treatment was highly
effective against established P. aeruginosa 48 h biofilms by disintegrating both bacterial cells
and the biofilm matrix [51], which prompted further investigations whether this technology is
capable of interfering with P. aeruginosaQS-controlled virulence factors, such as pyocyanin
and extracellular elastase (Las B) and as a consequence affect biofilm formation (Fig 5A, 5B, 5C
and 5E). Thus, in the current study, in order to rule out any underlying bactericidal effects of
ACP, the changes in the planktonic cell population density were monitored by conducting col-
ony count assay following treatment (Fig 5D). Short treatment time of 60 s in conjunction with
either type of exposure significantly reduced P. aeruginosa rhl-regulated pyocyanin levels, with
effects retained during 24 h of post treatment storage time at room temperature. Atmospheric
air ACP is a significant source of multiple reactive oxygen species, including ozone, atomic
oxygen, singlet oxygen, superoxide, peroxide, hydroxyl radicals and excited nitrogen species
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[52–53]. Therefore, pyocyanin could undergo oxidation by ROS and RNS generated during
ACP treatment. Similar oxidative effects were observed in [54–56], which reported irreversible
oxidation of pyocyanin by hydrogen peroxide, singlet oxygen and nitrite, significantly reducing
its cytotoxic/proinflamatory activity. Another virulence factor studied; elastase (Las B), is
mainly under the control of the las system and plays an important role in biofilm development
[17, 46, 57]. While concentrations of pyocyanin were significantly reduced after short treat-
ment times, reduction of extracellular elastase was notable only after extended treatment time
and when compared with the 24 h control samples. Importantly, the reductions of the studied
virulence factors were associated with no reduction in the planktonic cell concentration.
Reduced bactericidal effects of ACP treatment against planktonic cells could be due to protec-
tive effect of TSB where media components are likely to scavenge many of the plasma reactive
species generated during the treatment. While it was hypothesized that the disruption of QS
systems could further lead to the reduction in P. aeruginosa biofilm formation, no reduction in
biofilm formation capacity was achieved even after extended treatment for 300 s. The QS path-
ways regulating biofilm formation are complex and despite the demonstrated activity of ACP
against two of P. aeruginosa’s virulence factors, the effect on QS system and other biofilm for-
mation mechanisms will need to be further elucidated.
The toxic effects of P. aeruginosaQS-controlled virulence factors on mammalian cells,
including elastase and pyocyanin, have been widely reported: a concentration dependent cyto-
toxic effect of pyocyanin on different eukaryotic systems was reported in [58] and [59], whereas
P. aeruginosa las Bmutant strain almost totally abrogated epithelial cell cytotoxicity [60]. In this
study, ACP-mediated reduction of P. aeruginosa virulence factors was associated with signifi-
cant reduction of cytotoxic effects of bacterial supernatant on CHO-K1 cells regardless of type
and duration of treatment. These results indicate the high potential of ACP treatment to attenu-
ate bacterial virulence within relatively short treatment times (60 s), which could prove valuable
for future in vivo ACP applications targeting internal or indeed surface infections or as a mode
of low toxicity pre-emptive infection control. However, a pronounced decrease in viability of
CHO-K1 was observed when cells were exposed to the corresponding uninoculated and ACP
treated TSB medium. The ACP treatment time dependent reduction of cell viability could be
due to the action of ROS and RNS accumulated and retained in the medium during the treat-
ment, with little interference presented by the relatively simple constituents. Wende et al. [61],
exposed human keratinocytes, HaCaT cells, to ACP treated media and found a treatment time
dependent increase in accumulation of intracellular ROS. Moreover, intracellular ROS levels
strongly depended on the cell culture medium, where small organic molecules such as sugars,
amino acids, vitamins and buffer systems could interfere with ROS stability/propagation within
the liquid, modifying any plasma effects. In contrast, Haertel et al. [62], exposing HaCaT cells
either to air ACP or to the ACP treated media found that the levels of intracellular ROS induced
were neither dependent on the duration of the plasma treatment nor the treatment type. Fur-
thermore, exposure either to ACP treatment or ACP treated media resulted in a comparable
reduction in the levels of adherent HaCaT cells. Together with our observations these results
indicate the additional effects of ACP treatment on non-target cells or systems, which need to
be considered during development of anti-microbial, anti-QS or anti-virulence therapies, but
does not exclude the potential use of ACP treated fluids for human application. It is also impor-
tant that exposure to ACP treated TSB media significantly reduced cell growth by comparison
with the effects of P. aeruginosa supernatants, which could be due to the ROS scavenging prop-
erties of multiple components secreted into a medium by this pathogen, including alginate and
pigments, such as pyocyanin, pyoverdine and pyorubin [63]. In recent years ACP has been
under intense investigation for potential applications in wound healing, blood coagulation and
skin regeneration, and apoptosis of cancer cells [64–70]. Apart from ACP-mediated induction
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of cell proliferation, lethal effects on mammalian cells have also been reported [71–72]. There-
fore further investigations should focus on the effects of ACP treatment where the balance
between ACP bactericidal action and effects on mammalian cell viability will be the key factor
determining the system’s potential in chronic and acute therapeutic applications.
The efficacy observed against some monoculture biofilms but not against others highlights
the need to examine multispecies biofilm formations where relevant. Although monoculture
biofilms are often encountered in clinical settings, this is not the case for environmental occur-
rences and on foods. It has been known that formation of biofilms is influenced by environ-
mental conditions and characteristics of substrates to which bacteria attach. In this study the
model system, a 96 well microtiter plate, and relatively short time frame was utilised for biofilm
development, which cannot holistically describe the broad range of materials implicated in bio-
film formation within clinical environments and industrial settings. Therefore, further studies
on the efficacy of ACP against multispecies biofilms developed on a wider range of relevant
materials are warranted. It is considered that QS-regulated virulence factors, such as pyocyanin
and elastase, play a crucial role in clinical pathogenicity of P. aeruginosa [73] and inhibition of
these virulence factors is a key element in the future research for the replacement of current
antibiotics. To date, this is the first report focusing on anti-virulence activity of ACP, which
clearly demonstrated that, although there was no antibiofilm effect observed against P. aerugi-
nosa at the parameters examined, the treatment exhibited high potential against QS-regulated
virulence factors and these observations may further serve as a means for exploration of new
ACP-based strategies for tackling infections caused by this microorganism.
Conclusion
The results of this work clearly demonstrated that ACP could be a potential strategy for inacti-
vation of the established E. coli, L.monocytogenes and S. aureus 48 h biofilms. However, the
type of bacteria in conjunction with its biofilm composition might have an effect on ACP inac-
tivation efficacy. Furthermore, despite the ability of ACP treatment to penetrate and destroy
bacterial cells within complex biofilm structures, the bacterial metabolic state and cell mor-
phology could be important factors in determining the inactivation efficacy. Importantly, sig-
nificant reductions of P. aeruginosa QS-regulated virulence factors, such as pyocyanin and
elastase (Las B), were achieved, suggesting that ACP technology may play an important role in
attenuation of virulence of pathogenic bacteria. However, even after 300 s treatment, biofilm
formation capacity was largely unaffected, suggesting that the inactivation of virulence factors
by ACP could also be independent of QS mechanisms. Further optimization of ACP treatment
parameters for successful prevention and inactivation of established and developing biofilms
should focus on the mechanisms involved in the ACP-mediated reduction of virulence factors
and complete inactivation of VBNC state to reduce the risks associated with cross- or re-con-
tamination during or after treatment.
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